B. Braun Medical Inc., a medical device manufacturer, launched a new series of IV devices: the first in the U.S. market not made with polyvinyl chloride (PVC) and diethylhexyl phthalate (DEHP).
They provide an added level of protection for the environment and, most importantly, to patients from the potential health risks associated with exposure to these chemicals.
Dioxin, a known human carcinogen, can be formed during the manufacture of PVC, and during the incineration or burning of PVC products. DEHP, a phthalate used to soften PVC, is an endocrine disrupting compound that has been shown to be harmful to certain patient populations including pregnant women, male newborns, and young children. The American Medical Association, among other healthcare and professional organizations, encourages hospitals and physicians to reduce and phase out the use of PVC medical device products, especially those containing DEHP, and urges the adoption of safe, cost-effective, alternative products where available.
For more information about the CARESAFE™ IV Administration Sets with Optional AirStop components, click here.
About B. Braun
B. Braun Medical Inc., a leading corporation in infusion therapy and pain management, develops, manufactures, and markets innovative medical products and services to the healthcare industry. Other key product areas include nutrition, pharmacy admixture and dialysis. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. B. Braun Medical is headquartered in Bethlehem, Pennsylvania and is part of the B. Braun Group of Companies in the U.S., which includes B. Braun Interventional Systems, Aesculap® and CAPS®.
To learn more about B. Braun Medical, explore their website.
Related coverage
Widely used PVC plastic chemical spurs obesity, prediabetes: Study
The danger of hormone-mimicking chemicals in medical devices and meds
Autism and phthalates: Exposure in womb linked to autistic traits in boys
Banner photo: B.Braun
